EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:749608 - canakinumab
| ChEBI ID | CHEBI:749608 |
| ChEBI Name | canakinumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Roles: | antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. hypoglycemic agent A drug which lowers the blood glucose level. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. antirheumatic drug A drug used to treat rheumatoid arthritis. anti-inflammatory agent Any compound that has anti-inflammatory effects. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. hyperglycemic agent A drug which increases the blood glucose level. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. gout suppressant A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| canakinumab (CHEBI:749608) has role anti-anaemic agent (CHEBI:75835) |
| canakinumab (CHEBI:749608) has role anti-arrhythmia drug (CHEBI:38070) |
| canakinumab (CHEBI:749608) has role anti-inflammatory agent (CHEBI:67079) |
| canakinumab (CHEBI:749608) has role antiatherosclerotic agent (CHEBI:145947) |
| canakinumab (CHEBI:749608) has role antimicrobial agent (CHEBI:33281) |
| canakinumab (CHEBI:749608) has role antineoplastic agent (CHEBI:35610) |
| canakinumab (CHEBI:749608) has role antirheumatic drug (CHEBI:35842) |
| canakinumab (CHEBI:749608) has role antiviral agent (CHEBI:22587) |
| canakinumab (CHEBI:749608) has role gout suppressant (CHEBI:35845) |
| canakinumab (CHEBI:749608) has role hyperglycemic agent (CHEBI:76916) |
| canakinumab (CHEBI:749608) has role hypoglycemic agent (CHEBI:35526) |
| canakinumab (CHEBI:749608) has role ophthalmology drug (CHEBI:66981) |
| canakinumab (CHEBI:749608) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| ACZ-885 | ChEMBL |
| ACZ885 | ChEMBL |
| Canakinumab | ChEMBL |
| Brand Name | Source |
|---|---|
| Ilaris | ChEMBL |